Notícias e descobertas

Produtos, serviços e inovação em automotivo, tecnologia, saúde e bem-estar, beleza, fintechs e varejo. Publicações brasileiras e internacionais selecionadas; cobertura parcial, conforme as fontes disponíveis.

O coletor consulta as fontes em ciclos de cerca de 15 minutos, acrescidos do tempo de processamento, enquanto o serviço está ativo. A página consulta o banco a cada acesso e recarrega a cada cinco minutos enquanto estiver aberta. Não é cobertura em tempo real.

Explorar assuntos

Atalhos e rótulos usam palavras do título e resumo, incluindo termos em inglês. Não confirmam que uma inovação tenha sido comprovada.

Saúde — MedCity News · Data da fonte: 28/10/2026 às 15:06 (Brasília) · Últimas 24 horas

Eli Lilly’s ‘Triple-G’ Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial

Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults with type 2 diabetes. Retatrutide is a peptide designed to activate three metabolic targets versus just one hit by Ozempic. The post Eli Lilly’s ‘Triple-G’ Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial appeared first on MedC

Coletada: 28/10/2026 às 15:30 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 28/10/2026 às 12:53 (Brasília) · Últimas 24 horas

Ahead of Midterms, HFMA Calls for Cross-Sector Action on Healthcare Affordability

With healthcare affordability set to influence voters’ decisions in next week’s midterm elections, the Healthcare Financial Management Association is calling on healthcare leaders to move beyond finger-pointing and work together to address rising costs. HFMA is urging financial leaders across healthcare to sign its Declaration on Healthcare Affordability and

Coletada: 28/10/2026 às 13:48 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 28/10/2026 às 10:53 (Brasília) · Últimas 24 horas

Work Requirements Put New Pressure On Medicaid Member Retention

By using existing data to better understand members and implementing retention strategies, plans can remain sustainable and members can get the care they need. The post Work Requirements Put New Pressure On Medicaid Member Retention appeared first on MedCity News .

Coletada: 28/10/2026 às 12:22 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 28/10/2026 às 10:42 (Brasília) · Últimas 24 horas

How Can Hospitals and Pharmacists Collaborate on Effective Stewardship Programs for Opioids and Antibiotics?

[Sponsored] A webinar sponsored by Inovalon explored how hospitals and pharmacies can work together to generate the best outcomes for patients while improving patient safety. The post How Can Hospitals and Pharmacists Collaborate on Effective Stewardship Programs for Opioids and Antibiotics? appeared first on MedCity News .

Coletada: 28/10/2026 às 10:50 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 27/10/2026 às 19:01 (Brasília) · Últimos 7 dias

Willow Acquires 2 Women’s Health Companies

Willow Innovations acquired Swehl and Momtech to expand its maternal health offerings beyond breast pumps. The post Willow Acquires 2 Women’s Health Companies appeared first on MedCity News .

Coletada: 27/10/2026 às 19:33 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 27/10/2026 às 18:07 (Brasília) · Últimos 7 dias

Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva

Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the cell therapy itself. But Artiva’s setbacks follow safety signals reported for autoimmune disease cell therapy programs from Novartis and Bristol Myers Squibb. The post Patients Deaths and Data Shortfall Spell the End for Cell Therapy Bio

Coletada: 27/10/2026 às 18:38 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 27/10/2026 às 15:33 (Brasília) · Últimos 7 dias

ClarityCare Raises $16.5M to Speed Up Prior Authorizations

As health plans grapple with new federal deadlines for prior authorization decisions, healthcare AI startup ClarityCare has raised $16.5 million to automate the administrative workload that can keep patients waiting for the care they need. The post ClarityCare Raises $16.5M to Speed Up Prior Authorizations appeared first on MedCity News .

Coletada: 27/10/2026 às 15:37 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 27/10/2026 às 10:38 (Brasília) · Últimos 7 dias

A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals

The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even basic predictive tools, compared with 86 percent among top-tier system-affiliated hospitals. Every year without a bridge widens that gap, and it widens it fastest for the hospitals with the least room to absorb it. The post A Market, No

Coletada: 27/10/2026 às 10:55 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 26/10/2026 às 19:51 (Brasília) · Últimos 7 dias

How Experts Are Reacting to Trump’s Women’s Health Executive Order

Women’s health experts had mixed reactions to the Trump administration’s executive order on women’s health. The post How Experts Are Reacting to Trump’s Women’s Health Executive Order appeared first on MedCity News .

Coletada: 26/10/2026 às 19:58 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 26/10/2026 às 16:53 (Brasília) · Últimos 7 dias

Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3

Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to close in the first half of 2027, which is when the biotech plans to start a Phase 3 trial. The post Obesity Biotech Corx

Coletada: 26/10/2026 às 17:15 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 26/10/2026 às 14:48 (Brasília) · Últimos 7 dias

Sutter Health Expands Remote Monitoring Program to Patients with Heart Failure

Sutter Health, a nonprofit healthcare system based in Sacramento, California, is expanding its digital chronic disease management program, Sutter Sync, to include patients with heart failure. The expansion adds a remote monitoring technology from San Francisco-based medical tech company BodyPort. The program expansion comes as health systems look for ways to

Coletada: 26/10/2026 às 15:35 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 26/10/2026 às 10:22 (Brasília) · Últimos 7 dias

In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care

CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing The post In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care appeared first on MedCity News .

Coletada: 26/10/2026 às 10:47 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 26/10/2026 às 08:30 (Brasília) · Últimos 7 dias

FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market

[Sponsored] For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted. The post FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market appeared first on MedCity News .

Coletada: 26/10/2026 às 08:36 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 25/10/2026 às 20:22 (Brasília) · Últimos 7 dias

ProdutosServiços

CareValidate Launches Expanded HRT Offering

CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination. The post CareValidate Launches Expanded HRT Offering appeared first on MedCity News .

Coletada: 25/10/2026 às 20:31 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 25/10/2026 às 13:13 (Brasília) · Últimos 7 dias

Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science

Lycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against the blockbuster Roche drug Xolair. The post Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Sci

Coletada: 25/10/2026 às 13:42 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 25/10/2026 às 10:34 (Brasília) · Últimos 7 dias

Congress’s Patient Matching Fix Won’t Work — Here’s What Would

The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better solution. The post Congress’s Patient Matching Fix Won’t Work — Here’s What Would appeared first on MedCity News .

Coletada: 25/10/2026 às 10:51 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 25/10/2026 às 10:21 (Brasília) · Últimos 7 dias

Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR

In most organizations the default access model was built for patient care, not for protecting colleagues. A nurse on another unit, a resident who rotated with them, a department administrator: any of them may technically be able to open the record, even when policy says they should not. The post Physician Mental Health and Health System Privacy: Why Doctors

Coletada: 25/10/2026 às 10:25 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 25/10/2026 às 09:30 (Brasília) · Últimos 7 dias

Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October 16 immediately following the announcement. Despite the positive findings, the stock’s sharp decline highlighted a contrast between the clinical findings and the market’s response. The post Fr

Coletada: 25/10/2026 às 09:41 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 23/10/2026 às 17:33 (Brasília) · Últimos 7 dias

Where Are the Biggest Opportunities in Women’s Cardiovascular Health?

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as priorities for women’s cardiovascular health. The post Where Are the Biggest Opportunities in Women’s Cardiovascular Health? appeared first on MedCity News .

Coletada: 23/10/2026 às 17:39 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 23/10/2026 às 14:46 (Brasília) · Últimos 7 dias

Gilead to Pay $1.3B for Oral Peptide That Could Rival J&J’s New Immunology Pill

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 receptor to treat inflammatory bowel disease. It could compete against Johnson & Johnson’s Icotyde, an oral peptide that blocks the same target and is also in development for IBD. The post Gilead to Pay $1.3B for Oral Peptide That Could

Coletada: 23/10/2026 às 14:53 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 23/10/2026 às 10:54 (Brasília) · Últimos 7 dias

Why an Independent NP Practice Requires an Undergraduate Business Foundation

Ultimately, while clinical training teaches nurses how to care for patients within a system, business education empowers them to design, protect, and scale the system. The post Why an Independent NP Practice Requires an Undergraduate Business Foundation appeared first on MedCity News .

Coletada: 23/10/2026 às 14:08 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 22/10/2026 às 18:52 (Brasília) · Últimos 7 dias

Amazon, Google and Other Major Employers Back CMS Prior Auth Effort

Amazon, Axon Enterprise, Google, Meta and Oracle backed expanding electronic prior authorization to self-funded employer health plans. The post Amazon, Google and Other Major Employers Back CMS Prior Auth Effort appeared first on MedCity News .

Coletada: 22/10/2026 às 19:00 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 22/10/2026 às 14:54 (Brasília) · Últimos 7 dias

Serviços

Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition

Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform technology that developed it. Last year, Alcon acquired a majority stake in Aurion Biotech, a startup developing a corneal cell therapy. The post Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition appeared f

Coletada: 22/10/2026 às 17:36 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 22/10/2026 às 10:21 (Brasília) · Últimos 7 dias

Why SDoH Programs Fall Short — and What It Takes to Make Them Work

Throwing more money at SDoH programs isn’t going to magically fix them. Instead, plans should be focusing on building out these three specific capabilities that, together, can noticeably alter the playing field. The post Why SDoH Programs Fall Short — and What It Takes to Make Them Work appeared first on MedCity News .

Coletada: 22/10/2026 às 10:21 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 22/10/2026 às 08:30 (Brasília) · Últimos 7 dias

Inovação anunciada

INVEST Digital Health Celebrates Healthcare Innovation in Texas

In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, INVEST Digital Health also includes an innovation showcase with novel health tech and medtech offerings as well as networking opportunities. The post INVEST Digital Health Celebrates Healthcare Innovation in Texas appeared first on Me

Coletada: 22/10/2026 às 10:00 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 21/10/2026 às 19:18 (Brasília) · Arquivo

Produtos

Judi Health Launches Medicare Part D Plan for Employers

Judi Health launched Judi Rx Retire, an employer-sponsored Medicare Part D plan designed to improve pricing transparency and streamline benefits administration. The post Judi Health Launches Medicare Part D Plan for Employers appeared first on MedCity News .

Coletada: 21/10/2026 às 20:56 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 21/10/2026 às 15:38 (Brasília) · Arquivo

GSK Wins FDA Nod for Novel Hepatitis B Drug Offering a Potential Functional Cure

GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to make copies of itself and viral proteins. This drug was licensed from antisense oligonucleotide specialist Ionis Pharmaceuticals. The post GSK Wins FDA Nod for Novel Hepatitis B Drug Offering a Potential Functional Cure appeared first o

Coletada: 21/10/2026 às 20:56 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 21/10/2026 às 14:25 (Brasília) · Arquivo

Inovação anunciada

AMA Calls for Risk-Based GenAI Oversight to Protect Patients and Support Responsible Innovation

As generative AI moves toward performing increasingly consequential clinical functions, the American Medical Association (AMA) is urging the U.S. Food and Drug Administration to address a foundational question: Who is responsible for ensuring that these tools remain safe once they enter clinical practice? The post AMA Calls for Risk-Based GenAI Oversight to

Coletada: 21/10/2026 às 20:56 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 21/10/2026 às 10:34 (Brasília) · Arquivo

Produtos

Your Product Works — So Why Does It Still Fail in the Real World?

A patient’s automated risk score was reassuringly green. Pulling from a sparse medical record and infrequent acute visits, the model flagged him as low risk and routed him to the default, low-touch outpatient pathway — so why was the patient actively deteriorating? The post Your Product Works — So Why Does It Still Fail in the Real World? appeared first on M

Coletada: 21/10/2026 às 10:52 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 20/10/2026 às 19:23 (Brasília) · Arquivo

FDA Official Believes GenAI-enabled Tools Will Need to Be Assessed Like a Physician

Rick Abramson, a radiologist by training and the director of FDA’s Digital Health Center of Excellence said, “We ended up putting out this idea that maybe these devices are starting to behave a little bit more like me as a physician than a heart valve or a defibrillator.” The post FDA Official Believes GenAI-enabled Tools Will Need to Be Assessed Like a Phys

Coletada: 20/10/2026 às 19:26 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 20/10/2026 às 18:00 (Brasília) · Arquivo

ServiçosInovação anunciada

Readily Secures $11M for Compliance Intelligence Platform

The Series A round was led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund. The post Readily Secures $11M for Compliance Intelligence Platform appeared first on MedCity News .

Coletada: 20/10/2026 às 19:11 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 20/10/2026 às 16:21 (Brasília) · Arquivo

GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular genetic signature. It’s a label expansion for Jemperli, which was initially approved as a treatment for endometrial cancer The post GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer appeared first on MedCity News

Coletada: 20/10/2026 às 16:42 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 20/10/2026 às 10:09 (Brasília) · Arquivo

Inovação anunciada

A Radical Proposal to Preserve Cell and Gene Therapy Innovation

Cell and gene therapies are amazing medical breakthroughs but if we don’t find ways to pay for them, the development pipeline will fail. The post A Radical Proposal to Preserve Cell and Gene Therapy Innovation appeared first on MedCity News .

Coletada: 20/10/2026 às 10:13 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 20/10/2026 às 09:13 (Brasília) · Arquivo

Report: Health System M&A Activity Remains Steady in Third Quarter

A new report on third quarter M&A activity in the healthcare sector found that this quarter’s hospital and health system transactions remained steady, with 2026 potentially set to be a top year for total annual transactions since pre-pandemic times. The post Report: Health System M&A Activity Remains Steady in Third Quarter appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 19/10/2026 às 20:20 (Brasília) · Arquivo

AdvaMed’s 4 Policy Priorities, According to Its CEO

AdvaMed CEO Scott Whitaker outlined four policy priorities at the MedTech Conference: tariffs, FDA user fees, payment and coverage, and cybersecurity. The post AdvaMed’s 4 Policy Priorities, According to Its CEO appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 19/10/2026 às 17:27 (Brasília) · Arquivo

Produtos

Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare Blood Cancer

The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera. Silence’s RNA therapy offers a different approach and a potential dosing advantage over a Takeda Pharmaceutical product recently approved in this indication. The post Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 19/10/2026 às 15:32 (Brasília) · Arquivo

With $5M, Phantom GI Plans to Develop Minimally Invasive Alternative Ostomy Surgery Device

Phantom GI, a Tel Aviv-based medical startup, is developing the PercStoma device, a minimally invasive alternative to traditional ostomy surgery. The device would target patients with bowel obstructions who might otherwise be considered ineligible for surgery. The post With $5M, Phantom GI Plans to Develop Minimally Invasive Alternative Ostomy Surgery Device

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 19/10/2026 às 10:02 (Brasília) · Arquivo

Diagnosis Is Beside the Point

Some of the thorniest problems in medicine that AI can improve have nothing to do with diagnosis. They have to do with triage. The post Diagnosis Is Beside the Point appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 18/10/2026 às 12:42 (Brasília) · Arquivo

Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But Vertex Pharmaceuticals could also compete with a drug candidate from a recent acquisition. The post Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder appeared first o

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 18/10/2026 às 11:13 (Brasília) · Arquivo

Serviços

Allswell Raises $7M to Grow LGBTQ+ Behavioral Health Platform

Allswell’s seed round was led by Rethink Impact, and included participation from Magnify Ventures, Ulu Ventures and Hopelab Ventures, joining existing investors Techstars and Amboy Street Ventures. The post Allswell Raises $7M to Grow LGBTQ+ Behavioral Health Platform appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 18/10/2026 às 10:40 (Brasília) · Arquivo

The Antibiotics Exist —The System Cannot Deliver Them

This is not a discovery problem. It is a market entry and access problem, and it is far more tractable than the pipeline crisis we spend most of our attention on. The post The Antibiotics Exist —The System Cannot Deliver Them appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 18/10/2026 às 10:11 (Brasília) · Arquivo

Exercise is Prescribed Like Advice When It Should Be Delivered Like Treatment

Health care routinely recommends movement without providing assessment, dosage, progression, and follow-up that turn good advice into usable care. The post Exercise is Prescribed Like Advice When It Should Be Delivered Like Treatment appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 18/10/2026 às 09:30 (Brasília) · Arquivo

Serviços

UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform

UPMC Enterprises is making a strategic investment in VeloSource with plans to further develop its AI-enabled staffing management platform. The post UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 16/10/2026 às 19:43 (Brasília) · Arquivo

Produtos

Why Epic Is Launching a Prescription Price Comparison Tool

Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies. The post Why Epic Is Launching a Prescription Price Comparison Tool appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 16/10/2026 às 14:43 (Brasília) · Arquivo

City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering them to tissues throughout the body has already led to partnerships with Bausch + Lomb in eye diseases and Biogen in central nervous system disorders. The post City Therapeutics’

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 16/10/2026 às 10:53 (Brasília) · Arquivo

The Impending End of Cross-Subsidization

There is no single solution to the cross-subsidization problem. But here are some strategic actions that can make a health system’s economics more sustainable. The post The Impending End of Cross-Subsidization appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 16/10/2026 às 10:08 (Brasília) · Arquivo

How AI Is Connecting MedTech’s Data Without Compromising Compliance

The connected, agent-ready enterprise is the model that wins, where compliance and intelligence operate together. The post How AI Is Connecting MedTech’s Data Without Compromising Compliance appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 15/10/2026 às 19:53 (Brasília) · Arquivo

Rosarium Health Forms Home Modification Partnership with Anthem Medi-Cal

Rosarium Health partnered with Anthem Medi-Cal to provide home safety modifications for eligible members. The post Rosarium Health Forms Home Modification Partnership with Anthem Medi-Cal appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 15/10/2026 às 16:18 (Brasília) · Arquivo

AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D

Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline of internally discovered and wholly owned cancer drugs. Iambic also has R&D alliances with companies such as Bayer and AbbVie. The post AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D appeared first o

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Saúde — MedCity News · Data da fonte: 15/10/2026 às 10:41 (Brasília) · Arquivo

Why the Future of Healthcare Depends on Reinventing Primary Care Access

What is needed is a fundamentally different operating model for primary care, one designed around continuous engagement rather than episodic encounters. The post Why the Future of Healthcare Depends on Reinventing Primary Care Access appeared first on MedCity News .

Coletada: 20/10/2026 às 10:09 (Brasília)
Ler notícia na fonte ↗

Este radar identifica notícias para investigação. As novas editorias ainda não têm relatórios de comportamento do consumidor validados. Novidades anunciadas por empresas são alegações atribuídas à fonte, até confirmação independente.

Fotos aparecem apenas quando fornecidas no feed e disponíveis na origem. O resumo preserva o idioma da fonte. Não há tradução automática, e a cobertura não inclui todas as notícias publicadas.

Notícias são fontes secundárias. Sua publicação aqui não constitui validação de pesquisa, endosso ou confirmação independente de afirmações.